Return On Equity of Sigyn Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sigyn Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Sigyn Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 62%, a 42% decline year-over-year.
  • Sigyn Therapeutics, Inc. annual Return On Equity for 2024 was 83%, a 38% decline from 2023.
  • Sigyn Therapeutics, Inc. annual Return On Equity for 2023 was 134%, a 36% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Return On Equity for 2022 was 211%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Sigyn Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 62% -44% -42% 01 Jul 2025 30 Sep 2025
Q2 2025 82% -19% -19% 01 Apr 2025 30 Jun 2025
Q1 2025 76% -25% -25% 01 Jan 2025 31 Mar 2025
Q4 2024 83% -51% -38% 01 Oct 2024 31 Dec 2024
Q3 2024 106% -35% -25% 01 Jul 2024 30 Sep 2024
Q2 2024 101% -61% -38% 01 Apr 2024 30 Jun 2024
Q1 2024 101% -99% -49% 01 Jan 2024 31 Mar 2024
Q4 2023 134% -77% -36% 01 Oct 2023 31 Dec 2023
Q3 2023 141% -195% -58% 01 Jul 2023 30 Sep 2023
Q2 2023 162% -550% -77% 01 Apr 2023 30 Jun 2023
Q1 2023 200% +3998% 01 Jan 2023 31 Mar 2023
Q4 2022 211% +1424% 01 Oct 2022 31 Dec 2022
Q3 2022 336% +995% 01 Jul 2022 30 Sep 2022
Q2 2022 711% +2086% 01 Apr 2022 30 Jun 2022
Q1 2022 -3798% -4739% -504% 01 Jan 2022 31 Mar 2022
Q4 2021 -1213% -2232% -219% 01 Oct 2021 31 Dec 2021
Q3 2021 -658% -1203% -221% 01 Jul 2021 30 Sep 2021
Q2 2021 -1375% -1439% -2239% 01 Apr 2021 30 Jun 2021
Q1 2021 941% +915% +3440% 01 Jan 2021 31 Mar 2021
Q4 2020 1019% +1012% +14154% 01 Oct 2020 31 Dec 2020
Q3 2020 544% +507% +1345% 01 Jul 2020 30 Sep 2020
Q2 2020 64% +17% +36% 01 Apr 2020 30 Jun 2020
Q1 2020 27% -70% -72% 01 Jan 2020 31 Mar 2020
Q4 2019 7.2% -158% -96% 29 Oct 2019 31 Dec 2019
Q3 2019 38% -181% -83% 01 Jul 2019 30 Sep 2019
Q2 2019 47% 01 Apr 2019 30 Jun 2019
Q1 2019 96% 01 Jan 2019 31 Mar 2019
Q4 2018 165% 01 Oct 2018 31 Dec 2018
Q3 2018 219% 01 Jul 2018 30 Sep 2018
Q3 2016 503% 01 Jul 2016 30 Sep 2016
Q2 2016 1047% 01 Apr 2016 30 Jun 2016

Sigyn Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 83% -51% -38% 01 Jan 2024 31 Dec 2024
2023 134% -77% -36% 01 Jan 2023 31 Dec 2023
2022 211% +1424% 01 Jan 2022 31 Dec 2022
2021 -1213% -2232% -219% 01 Jan 2021 31 Dec 2021
2020 1019% +911% +841% 01 Jan 2020 31 Dec 2020
2019 108% -57% -35% 01 Jan 2019 31 Dec 2019
2018 165% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.